Glenview Trust co Has $9.50 Million Holdings in Lam Research Corporation $LRCX

Glenview Trust co lifted its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 11.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 97,567 shares of the semiconductor company’s stock after buying an additional 10,256 shares during the quarter. Glenview Trust co’s holdings in Lam Research were worth $9,497,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of LRCX. Sand Hill Global Advisors LLC acquired a new stake in Lam Research during the 2nd quarter worth $1,485,000. FAS Wealth Partners Inc. lifted its stake in shares of Lam Research by 14.3% in the 2nd quarter. FAS Wealth Partners Inc. now owns 44,657 shares of the semiconductor company’s stock valued at $4,347,000 after purchasing an additional 5,571 shares during the period. BNP Paribas boosted its position in shares of Lam Research by 3.6% in the 2nd quarter. BNP Paribas now owns 6,831 shares of the semiconductor company’s stock worth $665,000 after purchasing an additional 238 shares during the last quarter. Sei Investments Co. grew its stake in shares of Lam Research by 103.5% during the second quarter. Sei Investments Co. now owns 3,049,460 shares of the semiconductor company’s stock worth $296,833,000 after purchasing an additional 1,550,842 shares during the period. Finally, Heritage Wealth Management Inc. bought a new stake in Lam Research in the second quarter valued at about $209,000. 84.61% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

LRCX has been the topic of a number of recent analyst reports. Oppenheimer set a $200.00 target price on Lam Research and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Sanford C. Bernstein increased their price target on shares of Lam Research from $170.00 to $175.00 and gave the company an “outperform” rating in a research report on Friday, November 21st. Needham & Company LLC boosted their price objective on shares of Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft upped their target price on shares of Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Rothschild & Co Redburn lifted their price target on shares of Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $152.87.

Insider Transactions at Lam Research

In related news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 102,608 shares of company stock valued at $14,916,496 in the last ninety days. Corporate insiders own 0.31% of the company’s stock.

Lam Research Stock Up 1.5%

Shares of LRCX stock opened at $168.26 on Thursday. The firm has a fifty day moving average of $151.80 and a 200-day moving average of $119.10. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $169.69. The company has a market capitalization of $211.34 billion, a price-to-earnings ratio of 37.06, a P/E/G ratio of 1.70 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio is currently 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.